GI
REGN icon

GAMMA Investing’s Regeneron Pharmaceuticals REGN Stock Holding History

GAMMA Investing’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.75M Buy
2,306
+239
+12% +$181K 0.06% 260
2026
Q2 		$1.29M Sell
2,067
-440
-18% -$299K 0.05% 326
2026
Q1 		$1.94M Buy
2,507
+326
+15% +$250K 0.09% 192
2025
Q4 		$1.68M Buy
2,181
+455
+26% +$309K 0.08% 197
2025
Q3 		$970K Buy
1,726
+451
+35% +$255K 0.05% 297
2025
Q2 		$669K Sell
1,275
-11
-0.9% -$6.14K 0.04% 385
2025
Q1 		$816K Buy
1,286
+379
+42% +$261K 0.06% 283
2024
Q4 		$646K Sell
907
-529
-37% -$444K 0.06% 297
2024
Q3 		$1.51M Buy
1,436
+353
+33% +$393K 0.15% 124
2024
Q2 		$1.14M Buy
1,083
+199
+23% +$193K 0.16% 117
2024
Q1 		$851K Buy
884
+154
+21% +$146K 0.17% 102
2023
Q4 		$688K Buy
+730
New +$601K 0.19% 89

Other funds holding REGN

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
SBWIC
Schaper Benz & Wise Investment Counsel Neenah, Wisconsin $1.51B AUM 27.44% 1-Year Est. Return
NPPM
North Point Portfolio Managers Orange Village, Ohio $595M AUM 14.89% 1-Year Est. Return
JC
Jacobs & Co San Francisco, California $1.16B AUM 34.03% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return
VC
Veracity Capital Atlanta, Georgia $372M AUM 32.95% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

GAMMA Investing's REGN Position: Q3 2026 in Review

GAMMA Investing increased its Regeneron Pharmaceuticals (REGN) stake by 12% in Q3 2026, buying an estimated $181K and bringing the position to 2,306 shares worth $1.75M. The position accounts for 0.06% of the portfolio, ranked #260.

GAMMA Investing first reported a position in REGN in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.94M in Q1 2026. 54 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • GAMMA Investing held 2,306 shares of Regeneron Pharmaceuticals worth $1.75M as of Q3 2026.
  • GAMMA Investing bought 239 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $181K.
  • Regeneron Pharmaceuticals made up 0.06% of GAMMA Investing's portfolio in Q3 2026, its #260 holding.
  • GAMMA Investing first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Regeneron Pharmaceuticals position peaked at $1.94M in Q1 2026.
  • 54 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.